The coalition is formed to increase the visibility of the dietary/herbal industry and to ensure that the products are authentic and pure and that they also adhere to marketing claims. In the article, Sean Moloughney (Editor) states that Eric Schneiderman (New York AG) has issued cease and desist letters to the retailers on Feb 2 and issued subpoenas to four product manufacturers on Feb 16 requesting documentation related to standard operating procedures, quality control measures, analytical testing, label claims substantiation, and adverse event reporting.
The documentation that Schneiderman requested fit within the guidance of cGMP requirements established by the FDA which each manufacturer is required to comply with. (Details on these requirements can be read in my first blog referred to in the opening sentence of this post.)
The U.S. FDA has implemented new current good manufacturing practices (cGMP) regulations (21 CFR part 111) that mandate appropriate quality control and process control testing for dietary supplements, from incoming raw materials to finished goods (link to the FDA site). And, you might be aware that one of the most important analytical tools used in testing the quality of dietary ensuring standards of supplements is chromatography. We recently released an infographic, titled, Quality Control of Dietary Supplements, (downloadable PDF) to provide handy information about this market and it features a link to a useful presentation reviewing what these new regulations mean to companies in regards to testing requirements and what types of chromatography systems are can be used to address the issue.